Insider activities archive   |   Recent insider buys   |   Top 10 insider buys   |   Search Insiders!



Insider Trading: AVALON PHARMACEUTICALS INC

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of AVALON PHARMACEUTICALS INC since year 2005 are given in the first table. The second table lists detailed insider transactions reported by AVALON PHARMACEUTICALS INC since 2005. The reporting company's ticker symbol is AVRX. The reporting company's CIK number is 1162192. The total value of stock buying during this period is $9,554,843. The total value of stock sales is $5,191. The total value of stock exercises is $0.

Figure 1. Monthly insider transaction values at AVALON PHARMACEUTICALS INC (AVRX) in the past 24 months. The trade values of insider stock buys, sales, and option exercises are in logarithmic scale as shown on the right axis labels. The detailed monthly and daily insider transactions are listed in the 2 tables below.

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2007

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2008

  • 02

  • 03

  • 04

  • 05

  • $23,235

    $2,323

    $232

    $23

  • Buy
  • Sale
  • Option Exercise

Figure 2. Average prices of insider buys, sales, and option exercises at AVALON PHARMACEUTICALS INC (AVRX) in the past 24 months. See table 2 for insider transaction details.

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2007

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2008

  • 02

  • 03

  • 04

  • 05

  • $3.12

    $2.34

    $1.56

    $.78



Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for AVALON PHARMACEUTICALS INC (AVRX).
Trading Period
year-month  
Insider Buying     
Shares               Value ($)
Insider Sales     
Shares               Value ($)
Option Exercises     
Shares               Value ($)
2008-01 4,832 12,308 2,032 5,191 0 0
2006-08 7,500 23,235 0 0 0 0
2005-10 906,600 9,519,300 0 0 0 0

Table 2. Detailed insider stock purchases, sales, and option exercises for AVALON PHARMACEUTICALS INC (AVRX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2008-01-23 Carter Kenneth C (President and CEO) Purchase 4,832 2.55 12,308
2008-01-17 Carter Kenneth C (President and CEO) Sale 2,032 2.56 5,191
2006-08-30 Carter Kenneth C (President and CEO) Purchase 3,000 2.99 8,970
2006-08-28 Hamilton J Michael (Chief Medical Officer) Purchase 2,500 3.09 7,725
2006-08-22 Carter Kenneth C (President and CEO) Purchase 2,000 3.27 6,540
2005-10-04 Beneden Patrick Van (Director) Purchase 181,400 10.50 1,904,700
2005-10-04 Euclidsr Partners, L.p. (Director) Purchase 203,900 10.50 2,140,950
2005-10-04 Whitaker Raymond J (Director) Purchase 203,900 10.50 2,140,950
2005-10-04 Adviesbeheer Gimv Life Sciences Nv (10% Owner) Purchase 181,400 10.50 1,904,700
2005-10-04 Royston Ivor (Director) Purchase 136,000 10.50 1,428,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of AVALON PHARMACEUTICALS INC (symbol AVRX, CIK number 1162192) see the Securities and Exchange Commission (SEC) website.

© 2005-2008, insider-monitor.com. All rights reserved.